PharmaEssentia (TPE:6446) Total Premiums Earned

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TPE:6446 PharmaEssentia Corp TPE:6446
79 GF Score
Price NT$1,180.00
GF Value NT$1,240.53
Valuation Fairly Valued
View Full Analysis

What is PharmaEssentia Total Premiums Earned?

Total Premiums Earned only applies to insurance companies.

TPE:6446
79GF Score
PharmaEssentia Corp TPE:6446
Total Premiums Earned is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is PharmaEssentia (TPE:6446) Overvalued in 2026?

Based on GuruFocus' analysis, PharmaEssentia stock appears to be undervalued. The current stock price of NT$1,180.00 is trading 4.9% below its estimated GF Value™ of NT$1,240.53. GuruFocus considers PharmaEssentia to be Fairly Valued.

Key valuation signals for TPE:6446:

  • Total Premiums Earned:
  • GF Value™: NT$1,240.53 vs. price of NT$1,180.00 (4.9% below fair value)
  • GF Score™: 79/100

No single metric tells the full story. See the TPE:6446 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


PharmaEssentia Business Description

Address 13th Floor, No.3, Park Street, Nangang District, Taipei, TWN, 115
PharmaEssentia Corp engages in medicine discovery, supplements in developing specialty pharmaceutical reagents, API and new drug patterns developments. Its products include BESREMi, Ropeginterferon alfa-2b, Ropeg + anti PD-1, PEG-IL-2, PEG-Cytokines, PD-1-IL-2v, NY-ESO-1 TCR-T, among others. It derives revenue from medicine products sales from contracts with customers.
79GF Score

Get the complete analysis for TPE:6446

Total Premiums Earned is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$1,180.00
Price
NT$1,240.53
GF Value